BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spada F, Rossi RE, Kara E, Laffi A, Massironi S, Rubino M, Grimaldi F, Bhoori S, Fazio N. Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals (Basel) 2021;14:539. [PMID: 34199977 DOI: 10.3390/ph14060539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cigrovski Berkovic M, Ulamec M, Marinovic S, Balen I, Mrzljak A. Malignant insulinoma: Can we predict the long-term outcomes? World J Clin Cases 2022; 10(16): 5124-5132 [DOI: 10.12998/wjcc.v10.i16.5124] [Reference Citation Analysis]
2 Opalińska M, Sowa-staszczak A, Al Maraih I, Gilis-januszewska A, Hubalewska-dydejczyk A. Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma. Bio-Algorithms and Med-Systems 2022;17:221-6. [DOI: 10.1515/bams-2021-0138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]